Showing 1–4 of 4 results for author: Fromer, J C

Optimal compound downselection to promote diversity and parallel chemistry

Authors: Jenna C. Fromer, Alexandra D. Volkova, Connor W. Coley

Abstract: Early stage drug discovery and molecular design projects often follow iterative design-make-test cycles. The selection of which compounds to synthesize from all possible candidate compounds is a complex decision inherent to these design cycles that must weigh multiple factors. We build upon the algorithmic downselection framework SPARROW that considers synthetic cost, synthetic feasibility, and co… ▽ More Early stage drug discovery and molecular design projects often follow iterative design-make-test cycles. The selection of which compounds to synthesize from all possible candidate compounds is a complex decision inherent to these design cycles that must weigh multiple factors. We build upon the algorithmic downselection framework SPARROW that considers synthetic cost, synthetic feasibility, and compound utility, extending it to address additional critical factors related to the risk of synthesis failure, molecular diversity, and parallel chemistry capabilities. These design considerations further align algorithmic compound selection with the true complexity of this decision-making process, allowing SPARROW to capture a broader set of principles typically reliant on expert chemist intuition. The application of these formulations to an exemplary case study highlights SPARROW's ability to promote the selection of diverse batches of compounds whose syntheses are amenable to parallel chemistry. △ Less

Submitted 17 March, 2025; originally announced March 2025.

An algorithmic framework for synthetic cost-aware decision making in molecular design

Authors: Jenna C. Fromer, Connor W. Coley

Abstract: Small molecules exhibiting desirable property profiles are often discovered through an iterative process of designing, synthesizing, and testing sets of molecules. The selection of molecules to synthesize from all possible candidates is a complex decision-making process that typically relies on expert chemist intuition. We propose a quantitative decision-making framework, SPARROW, that prioritizes… ▽ More Small molecules exhibiting desirable property profiles are often discovered through an iterative process of designing, synthesizing, and testing sets of molecules. The selection of molecules to synthesize from all possible candidates is a complex decision-making process that typically relies on expert chemist intuition. We propose a quantitative decision-making framework, SPARROW, that prioritizes molecules for evaluation by balancing expected information gain and synthetic cost. SPARROW integrates molecular design, property prediction, and retrosynthetic planning to balance the utility of testing a molecule with the cost of batch synthesis. We demonstrate through three case studies that the developed algorithm captures the non-additive costs inherent to batch synthesis, leverages common reaction steps and intermediates, and scales to hundreds of molecules. SPARROW is open source and can be found at http://github.com/coleygroup/sparrow. △ Less

Submitted 28 May, 2024; v1 submitted 3 November, 2023; originally announced November 2023.

Pareto Optimization to Accelerate Multi-Objective Virtual Screening

Authors: Jenna C. Fromer, David E. Graff, Connor W. Coley

Abstract: The discovery of therapeutic molecules is fundamentally a multi-objective optimization problem. One formulation of the problem is to identify molecules that simultaneously exhibit strong binding affinity for a target protein, minimal off-target interactions, and suitable pharmacokinetic properties. Inspired by prior work that uses active learning to accelerate the identification of strong binders,… ▽ More The discovery of therapeutic molecules is fundamentally a multi-objective optimization problem. One formulation of the problem is to identify molecules that simultaneously exhibit strong binding affinity for a target protein, minimal off-target interactions, and suitable pharmacokinetic properties. Inspired by prior work that uses active learning to accelerate the identification of strong binders, we implement multi-objective Bayesian optimization to reduce the computational cost of multi-property virtual screening and apply it to the identification of ligands predicted to be selective based on docking scores to on- and off-targets. We demonstrate the superiority of Pareto optimization over scalarization across three case studies. Further, we use the developed optimization tool to search a virtual library of over 4M molecules for those predicted to be selective dual inhibitors of EGFR and IGF1R, acquiring 100% of the molecules that form the library's Pareto front after exploring only 8% of the library. This workflow and associated open source software can reduce the screening burden of molecular design projects and is complementary to research aiming to improve the accuracy of binding predictions and other molecular properties. △ Less

Submitted 16 October, 2023; originally announced October 2023.

Computer-Aided Multi-Objective Optimization in Small Molecule Discovery

Authors: Jenna C. Fromer, Connor W. Coley

Abstract: Molecular discovery is a multi-objective optimization problem that requires identifying a molecule or set of molecules that balance multiple, often competing, properties. Multi-objective molecular design is commonly addressed by combining properties of interest into a single objective function using scalarization, which imposes assumptions about relative importance and uncovers little about the tr… ▽ More Molecular discovery is a multi-objective optimization problem that requires identifying a molecule or set of molecules that balance multiple, often competing, properties. Multi-objective molecular design is commonly addressed by combining properties of interest into a single objective function using scalarization, which imposes assumptions about relative importance and uncovers little about the trade-offs between objectives. In contrast to scalarization, Pareto optimization does not require knowledge of relative importance and reveals the trade-offs between objectives. However, it introduces additional considerations in algorithm design. In this review, we describe pool-based and de novo generative approaches to multi-objective molecular discovery with a focus on Pareto optimization algorithms. We show how pool-based molecular discovery is a relatively direct extension of multi-objective Bayesian optimization and how the plethora of different generative models extend from single-objective to multi-objective optimization in similar ways using non-dominated sorting in the reward function (reinforcement learning) or to select molecules for retraining (distribution learning) or propagation (genetic algorithms). Finally, we discuss some remaining challenges and opportunities in the field, emphasizing the opportunity to adopt Bayesian optimization techniques into multi-objective de novo design. △ Less

Submitted 13 October, 2022; originally announced October 2022.